Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 for Hair Loss Researchers: Delivery Method Comparison

Subcutaneous Injection (Systemic) Peptide enters circulation and distributes systemically, reaching follicular tissue via capillary diffusion Easier to dose consistently; standard preclinical protocol; no penetration barriers Lower local concentration at targe

This comparison does not assign a generated winner or score.

  • Subcutaneous Injection (Systemic)
  • Peptide enters circulation and distributes systemically, reaching follicular tissue via capillary diffusion
  • Easier to dose consistently; standard preclinical protocol; no penetration barriers
  • Lower local concentration at target tissue; requires higher total peptide dose; potential off-target effects
  • Best for whole-scalp or generalized thinning models where systemic exposure is acceptable. Not ideal for localized studies
  • Intradermal Injection (Localized)
  • Direct delivery into scalp dermis at follicle depth (1.5–2mm), bypassing epidermal barrier
  • Maximizes local concentration; minimizes systemic exposure; allows site-specific control groups
  • Requires skilled injection technique; injection site inflammation common; uneven distribution risk
  • Gold standard for mechanistic studies requiring precise dosing at specific follicular sites. Preferred in human pilot trials
  • Topical Application (Cream/Serum)
  • Relies on passive diffusion or penetration enhancers (DMSO, liposomes) to cross stratum corneum
  • Non-invasive; easier patient compliance; no injection site reactions
  • Poor dermal penetration (typically <5% reaches target depth); peptide degradation by surface proteases; highly variable bioavailability
  • Not viable for controlled research. Too many variables; acceptable only for exploratory consumer-facing formulations
  • Microneedling + Topical
  • Mechanical disruption of stratum corneum via 0.5–1.5mm needles, followed by topical peptide application
  • Improves penetration 10–15× vs topical alone; controlled penetration depth; combines wound healing stimulus with peptide delivery
  • Requires sterile technique; needle depth consistency critical; wound-induced inflammation may confound peptide effects
  • Emerging hybrid approach worth exploring in translational studies. Provides better penetration than topical alone without full injection invasiveness
More references

Related material